Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

You are viewing this page in draft mode.

Why we need to curb the emerging worldwide epidemic of nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) has emerged as the most prevalent liver disease worldwide, mainly because of the massive parallel global increase in obesity. Extensive public-health and political efforts will be needed in the near future to counteract this disturbing development.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Estes, C. et al. J. Hepatol. 69, 896–904 (2018).

    Article  Google Scholar 

  2. 2.

    Haldar, D. et al. J. Hepatol. 71, 313–322 (2019).

    Article  Google Scholar 

  3. 3.

    Li, Z. et al. J. Gastroenterol. Hepatol. 29, 42–51 (2014).

    CAS  Article  Google Scholar 

  4. 4.

    Stepanova, M. et al. Clin Gastroenterol Hepatol 15, 759–766.e755 (2017).

    Article  Google Scholar 

  5. 5.

    Jewell, J. & Sheron, N. Clin. Med. (Lond.) 10, 259–263 (2010).

    Article  Google Scholar 

  6. 6.

    Clair, H. B. et al. Toxicol. Sci. 164, 39–49 (2018).

    CAS  Article  Google Scholar 

  7. 7.

    Ryan, D. H. & Yockey, S. R. Curr. Obes. Rep. 6, 187–194 (2017).

    Article  Google Scholar 

  8. 8.

    Tremmel, M., Gerdtham, U. G., Nilsson, P. M. & Saha, S. Int. J. Environ. Res. Public Health 14, 435 (2017).

    Article  Google Scholar 

  9. 9.

    Brewis, A. A. Soc. Sci. Med. 118, 152–158 (2014).

    Article  Google Scholar 

  10. 10.

    Bilger, M., Kruger, E. J. & Finkelstein, E. A. Health Econ. 26, 1052–1066 (2017).

    Article  Google Scholar 

  11. 11.

    Lazarus, J. V. et al. J. Hepatol. (2019).

  12. 12.

    Barata Cavalcanti, O. World Obesity (2019).

  13. 13.

    Williams, R. et al. Lancet 392, 2398–2412 (2018).

    Article  Google Scholar 

  14. 14.

    European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) & European Association for the Study of Obesity (EASO). J. Hepatol. 64, 1388–1402 (2016).

  15. 15.

    Ananthapavan, J., Sacks, G., Moodie, M. & Carter, R. Int. J. Environ. Res. Public Health 11, 4007–4025 (2014).

    Article  Google Scholar 

  16. 16.

    Williams, R. et al. Lancet 384, 1953–1997 (2014).

    Article  Google Scholar 

  17. 17.

    Anderson, E. L. et al. PLoS One 10, e0140908 (2015).

    Article  Google Scholar 

  18. 18.

    O’Reilly, J. R. & Reynolds, R. M. Clin. Endocrinol. 78, 9–16 (2013).

    Article  Google Scholar 

  19. 19.

    Wesolowski, S. R., Kasmi, K. C., Jonscher, K. R. & Friedman, J. E. Nat. Rev. Gastroenterol. Hepatol. 14, 81–96 (2017).

    CAS  Article  Google Scholar 

  20. 20.

    Skouteris, H. et al. Front. Endocrinol. (Lausanne) 10, 163 (2019).

    Article  Google Scholar 

Download references

Author information




All authors researched data for this article, and wrote, reviewed and edited the manuscript.

Corresponding authors

Correspondence to Anna Mae Diehl or Herbert Tilg.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Diehl, A.M., Farpour-Lambert, N.J., Zhao, L. et al. Why we need to curb the emerging worldwide epidemic of nonalcoholic fatty liver disease. Nat Metab 1, 1027–1029 (2019).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing